Cargando…
A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
Patients with type 2 diabetes are at increased cardiovascular risk. Until recently, reductions in HbA(1c) and the use of specific glucose-lowering agents have not had a clear, reproducible benefit in reducing the incidence of cardiovascular disease. However, over the past 5 years, members of two cat...
Autores principales: | Ahmad, Tariq, Riello, Ralph J, Inzucchi, Silvio E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054345/ https://www.ncbi.nlm.nih.gov/pubmed/33897837 http://dx.doi.org/10.15420/ecr.2020.01.R1 |
Ejemplares similares
-
Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019) -
Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
por: Matsumori, Akira
Publicado: (2023) -
D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022) -
Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction
por: Zhang, Jian, et al.
Publicado: (2020) -
Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel
por: Ishay, Avraham, et al.
Publicado: (2019)